Robert Mionis sold $3.5M of CLS
Chief Executive Officer at CELESTICA INC. 9,543 shares at an average of $367.49, traded Jul 31, 2026, filed Aug 3, 2026.
Score components
- +25RoleCEO
- +25Trade size$3.5M at market
- +5Share of holdings soldSold 16% of holdings
- +8Cluster2 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001193125-26-330957, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jul 31, 2026 | SOpen-market sale Common Sharesindirect: By Mionis 2026 GRAT Number Three10b5-1 | -340 | $360.47 | $123k | 60,044 | Aug 3, 2026 |
| Jul 31, 2026 | SOpen-market sale Common Sharesindirect: By Mionis 2026 GRAT Number Three10b5-1 | -67 | $361.11 | $24k | 59,977 | Aug 3, 2026 |
| Jul 31, 2026 | SOpen-market sale Common Sharesindirect: By Mionis 2026 GRAT Number Three10b5-1 | -1,136 | $363.14 | $413k | 58,841 | Aug 3, 2026 |
| Jul 31, 2026 | SOpen-market sale Common Sharesindirect: By Mionis 2026 GRAT Number Three10b5-1 | -1,640 | $364.47 | $598k | 57,201 | Aug 3, 2026 |
| Jul 31, 2026 | SOpen-market sale Common Sharesindirect: By Mionis 2026 GRAT Number Three10b5-1 | -40 | $365.00 | $15k | 57,161 | Aug 3, 2026 |
| Jul 31, 2026 | SOpen-market sale Common Sharesindirect: By Mionis 2026 GRAT Number Three10b5-1 | -660 | $366.48 | $242k | 56,501 | Aug 3, 2026 |
| Jul 31, 2026 | SOpen-market sale Common Sharesindirect: By Mionis 2026 GRAT Number Three10b5-1 | -2,280 | $368.86 | $841k | 54,221 | Aug 3, 2026 |
| Jul 31, 2026 | SOpen-market sale Common Sharesindirect: By Mionis 2026 GRAT Number Three10b5-1 | -2,837 | $370.02 | $1.0M | 51,384 | Aug 3, 2026 |
| Jul 31, 2026 | SOpen-market sale Common Sharesindirect: By Mionis 2026 GRAT Number Three10b5-1 | -223 | $372.46 | $83k | 51,161 | Aug 3, 2026 |
| Jul 31, 2026 | SOpen-market sale Common Sharesindirect: By Mionis 2026 GRAT Number Three10b5-1 | -240 | $373.60 | $90k | 50,921 | Aug 3, 2026 |
| Jul 31, 2026 | SOpen-market sale Common Sharesindirect: By Mionis 2026 GRAT Number Three10b5-1 | -80 | $374.49 | $30k | 50,841 | Aug 3, 2026 |
Related signals
Other insiders at CELESTICA INC and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 58Moderate | CELESTICA INC | Robert Mionis Chief Executive Officer | $8.5M 23,396 shares | -100% | |
| 38Weak | CELESTICA INC | Todd C Cooper President | $7.2M 20,118 shares | -22% | |
| 58Moderate | CELESTICA INC | Robert Mionis Chief Executive Officer | $8.5M 23,496 shares | -50% | |
| 40Moderate | CELESTICA INC | Mandeep Chawla Chief Financial Officer | $6.0M 16,117 shares | -20% | |
| 58Moderate | CELESTICA INC | Robert Mionis Chief Executive Officer | $36M 98,453 shares | -194% | |
| 58Moderate | CELESTICA INC | Robert Mionis Chief Executive Officer | $19M 51,061 shares | -52% | |
| 24Weak | CELESTICA INC | Mandeep Chawla Chief Financial Officer | $324k 883 shares | -1% | |
| 40Moderate | CELESTICA INC | Mandeep Chawla Chief Financial Officer | $6.8M 17,000 shares | -17% | |
| 48Moderate | CELESTICA INC | Robert Mionis Chief Executive Officer | $26M 66,056 shares | -33% | |
| 48Moderate | CELESTICA INC | Robert Mionis Chief Executive Officer | $22M 55,768 shares | -42% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.